Ash. Thanks for those considered, careful thoughts. There is not a lot of idle chatter on this stock which I take as a good thing.
I am not too concerned about calling in Investec for advice. It may be that they already have informal feedback from the recent AU trials of Novacq in the recent prawn season which has encouraged management to get ahead of the game and consider how to make the most of this feed additive? We will know, formally, next month when results of those AU trials are reported.
I think we already know that Novacq is NOT a "dud". Yes? Why would they be ramping up production in Thailand if it was? The big question yet to be confirmed without ANY doubt is how much of an advantage does it give to prawn farmers in the first instance.
Other species applications would be next in the long research chain.
One thing we have yet to hear about is the pricing of Novacq and the potential margins involved for RIC.
Oh yes. I agree, if a capital raise is required I would be supportive. Why give an advantage to some opportunistic external investor when existing shareholders should be given first refusal?
RIC Price at posting:
$1.45 Sentiment: Buy Disclosure: Held
(20min delay)
